WG 2 Informatics Standards in Pathology. Dr Christel DANIEL (IHE Anatomic Pathology co-chair) Jacques KLOSSA (DICOM WG26 co-chair) Bernd BLOBEL

Size: px
Start display at page:

Download "WG 2 Informatics Standards in Pathology. Dr Christel DANIEL (IHE Anatomic Pathology co-chair) Jacques KLOSSA (DICOM WG26 co-chair) Bernd BLOBEL"

Transcription

1 WG 2 Informatics Standards in Pathology Dr Christel DANIEL (IHE Anatomic Pathology co-chair) Jacques KLOSSA (DICOM WG26 co-chair) Bernd BLOBEL

2 Agenda Progress report of WG2 IHE/HL7 Anatomic Pathology DCIOM WG26 WG 2 Informatics Standards in Pathology meeting IHE Anatomic Pathology Structured Reports Extending the scope? Mapping PathLex to SNOMED CT Joint IHE AP/DICOM WG26 initiative Better use of DICOM in Anatomic Pathology workflow (DICOM Modality Work list)

3 Progress report of WG2 IHE AP : Overview Intra hospital integration profiles Anatomic Pathology Workflow (APW) Ordering and performing anatomic pathology examinations Community Anatomic Reporting for Public Health (ARPH) Sending anatomic pathology reports to public health organizations Anatomic Pathology Structured Report (APSR) Sharing/exchanging structured anatomic pathology reports as CDA documents

4 Organization of Anatomic Pathology Technical Framework Revision 2.0 July 23, 2010 Draft for Trial Implementation 2010 & 2011 Supplements for Trial Implementation

5 Anatomic Pathology Workflow (APW) Establishes the integrity of basic pathology data acquired for examinations being ordered for an identified patient Defines the actors and transactions involved in Ordering and reporting aspects of the workflow Order entry, report creation and transmission. Imaging aspects of the workflow Image acquisition, storage and distribution among multiple systems.

6 Anatomic Pathology Workflow (APW) Hospital Care Ward Anatomic Pathology Laboratory Image Mgmt Image Archive/ Image Manager (PACS) Order Placer Order Mgmt Acquisition Modality Order Filler Report Mgmt Order result tracker

7 APW actors & transactions

8 Anatomic Pathology Reporting to Public Health (ARPH) Joint initiative : IHE AP, HL7 AP, NAACCR (North American Association of Central Cancer Registries), CDC (Centers for Disease Control). Defines the actors and transactions involved in anatomic pathology reporting to public health organizations. Global Perspective of Cancer Surveillance International Association of Cancer Registries 241 Registries (Voting Member) from all 6 continents North American Association of Central Cancer Registries All Canadian Provinces All US States All US Territories and Jurisdictions

9 Anatomic Pathology Reporting to Public Health (ARPH) Hospital Care Ward Anatomic Pathology Laboratory Healthcare community Report Receiver Order Filler Report Sender Public Health Report Mgmt Clinics Report Sender Anatomic Pathology Laboratory

10 ARPH actors & transactions

11 Anatomic Pathology Structured Report (APSR) Just published for Trial implementation! Joint IHE and HL7 anatomic pathology initiative Content integration profile standardizing Anatomic Pathology Structured Report (APSR) using HL7 CDA APSR as CDA documents including Anatomic Pathology observations bound to images or regions of interest Shared or exchanged within a community of care providers using existing integration profiles defined by IHE Information Technology Infrastructure Unique opportunity to share/exchange Anatomic Pathology Structured Reports that are semantically interoperable at an international level

12 Scope APSR for surgical pathology 21 CDA templates Generic APSR template All fields of anatomic pathology (inflammatory, vascular, traumatic, metabolic diseases as well as cancer) 20 organ-specific cancer APSR templates Traditional anatomic pathology observation using light microscopy (including immunohistochemistry, FISH, etc) Further cycles Forensic (autopsy, toxicology) Special ancillary techniques (flow cytometry, cytogenetics, electronic microscopy) Research (TMA, etc)

13 Background From clinical document models Recent recommendations for required, preferred, and optional elements for any APR of surgical pathology, regardless of report types [Goldsmith 08] National initiatives Anatomic Pathology SR (Netherlands, Germany, Australasia) Cancer APSR US - CAP (College of American Pathologists) 67 cancer checklists and protocols (October 2009) France - SFP (French society of pathology) INCa (French National Cancer Institute) Minimum data sets for cancer APSR in 20 locations (85% of new cancers in France) (required by accrediting bodies) Australasia 6 templates for cancer APSR UK Royal college Goldsmith, J.D., et al., Reporting guidelines for clinical laboratory reports in surgical pathology. Arch Pathol Lab Med, (10): p

14 Background to IT templates Non healthcare IT standard CAP electronic Cancer Checklist Healthcare IT standard CEN archetypes Australia HL7 CDA Most reliable standard for clinical document templates Existing implementation guides for the APSR? Netherlands, Germany

15 Anatomic Pathology Structured Report (APSR) Hospital Care Ward Anatomic Pathology Laboratory Healthcare community Document Repository Order Filler Document Source Document sharing Clinics Document Source Anatomic Pathology Laboratory

16 APSR actors & transactions Content (Anatomic Pathology Structured Report) is created by a Content Creator consumed by a Content Consumer. Sharing or transmission of content from one actor to the other XDS, XDM and XDR Integration Profiles, described in Volume 3 of the Anatomic Pathology Technical Framework.

17 CDA Document Content Module (n=21) Any APSR CDA document content module is composed of a header and a structured body. 2 types of CDA Document Content Modules Generic APSR ( ) 20 organ-specific cancer APSR

18 CDA Section Content Modules (n=6)

19 CDA Entry Content Module (n=5) e.g Diagnosis entry Diagnoses on all specimens that are delivered to the pathology reported separatly Additional pathologic finding(s), results of ancillary studi(es) & images In case of cancer, this section includes the cancer checklists

20 Anatomic Pathology Observation [0..*] <value> (zero to many response) coded (code, coding system, version, display name) [0..*] <qualifier> (post coordinated expression) numeric (integer or real, unit) textual

21 The CDA Iceberg Pathologist/clinician sees Machine sees

22 The pathologist/clinician sees

23 The pathologist/clinician sees

24 The machine sees <ClinicalDocument xmlns='urn:hl7-org:v3'> <typeid extension="pocd_hd000040" root=" "/> <!-- conformance to a generic APSR content module --> <templateid root=' '/> <!-- conformance to a cancer APSR content module --> <templateid root=' '/> <!-- conformance to a breast cancer content module --> <templateid root=' '/>...remainder of the header not shown... <component> <structuredbody> <component> <section> <templateid root=' '/> <code code=' ' displayname= Pathology report relevant history' codesystem=' ' codesystemname='loinc'/> <title>relevant information provided by the ordering physician</title> <text> Tissue submitted: left breast biopsy and apical axillary tissue </text> <entry>... </entry> <component> <section> <templateid root=' '/> <code code=' ' displayname= Reason for referral codesystem=' ' codesystemname='loinc'/> <title>reason for anatomic pathology procedure</title> <text>breast mass - left breast</text> <entry>... </entry> </section> </component> <component>

25 Agenda Progress report of WG2 IHE/HL7 Anatomic Pathology DCIOM WG26 WG 2 Informatics Standards in Pathology meeting IHE Anatomic Pathology Structured Reports Extending the scope? Mapping PathLex to SNOMED CT Joint IHE AP/DICOM WG26 initiative Better use of DICOM in Anatomic Pathology workflow (DICOM Modality Work list)

26 Extending the scope of APSR?

27 Example of templates IHE-HL7 AP joint initiative 20 organ-specific AP structured reports templates (85% of incident cancers) 488 observations & procedure templates 27

28 IHTSDO

29

30 IHTSDO Arbeitsgruppen Anesthesia Concept Model Education IHTSDO Workbench Developers Implementation International Family Practice/General Practice International Pathology & Laboratory Medicine Mapping Nursing Pharmacy Translation IHTSDO Projektgruppen Anatomy Model Collaborative Editing Roadmap Content Product Development Planning Event, Condition and Episode Model Family/General Practice Refset and ICPC Mapping IHTSDO Translation Tooling Machine & Human Readable Concept Model Mapping SNOMED CT to ICD-10 Migration Observable and Investigation Model Organism & Infectious Disease Model Request Submission Substance Hierarchy Redesign COST Translation Action IC0604 Quality -Assessment Belgrade, April 1st, 2011

31

32 Mapping PathLex to SNOMED CT

33 AP observation (Coded Descriptor) Specific value set Breast-Specimen Collection Procedure (OID ) Value set OID: displayname Breast excision without wire-guided localization Breast excision with wire-guided localization Total mastectomy (including nipple and skin) CodeSystem: PathLex OID: Admitted exceptions : Unknown, Asked but unknown, Other

34 Mapping PathLex to SNOMED CT (using UMLS) PathLex Short label TNM No TNM UMLS Search EM/NM 1349 CUI Exact match SNOMED CT No CUI No SNOMED CT Split label No new tokens New tokens Partial match No CUI CUI SNOMED CT 3 4 Metamap SNOMED CT To be explored No SNOMED CT

35 Results of the automatic mapping process Matching situations Number of labels Percenta ges of labels Labels mapped to SNOMED CT through exact match (EM) or normalized match (NM) to UMLS % Labels mapped to another terminology through exact match (EM) or normalized match (NM) to UMLS 79 6% Tokens mapped to SNOMED CT through exact match (EM) or normalized match (NM) to UMLS % Tokens mapped to another terminology through exact match (EM) or normalized match (NM) to UMLS 25 2% Tokens without any match 80 6% Labels without any match and that cannot be split in tokens % TOTAL %

36 Examples of PathLex labels/expressions with automatic mappings Categories of observations PathLex label CUI SNOMED CT code Examples of AP macroscopic observation types related to the specimen Examples of AP microscopic observation types related to a lesion related to a lesion Specimen size, largest dimension C Specimen size, additional dimension C Lesion size, largest dimension C Lesion site C Histologic type C Histologic grade C Margins involvement C

37 No automatic match Types of ancillary techniques Types of histologic grades Extension Label HER2/neu (FISH method) Mismatch Repair Proteins-MLH1 (Immunohistochemistry Study) Histologic grade (Clark) Histologic grade (Gleason-Primary (Predominant) Pattern) Histologic grade (Gleason-Total Gleason Score) Number of lymph nodes with isolated tumor cells (< = 0.2 mm and < = 200 cells)

38 No automatic match Anatomic location Histologic types Label Anterior floor of mouth (qualifier : right, left, medial) Distal esophagus Atelectasis Extends to the hilar region but does not involve entire lung Atypical squamous cells for which a high-grade lesion cannot be excluded (ASC-H) Cirrhosis/severe fibrosis (Ishak score 5-6) (F1) Combined small cell carcinoma (small cell carcinoma and non-small cell component) Complex hyperplasia without cytologic atypia DCIS Comedo Ductal carcinoma in situ involving nipple skin (Paget disease) with microinvasion

39 No automatic match 3 9 Label Histologic grades FIGO grade 1 G1: Nuclei round, uniform, approximately 10 mm; nucleoli inconspicuous or absent Low-grade squamous intraepithelial lesion encompassing HPV infection or mild dysplasia (CIN 1) Score 2: 10% to 75% of tumor area forming glandular/tubular structures Extension <50% myometrial invasion Results of AP ancillary techniques Amplified (HER2 gene copy >6.0 or ratio >2.2) Equivocal (HER2 gene copy 4.0 to 6.0 or ratio 1.8 to 2.2) Immunoreactive tumor cells present (> = 1%) (Specify Quantitation) Mild to moderate (0-2 per high-power [X400] field) Intratumoral Lymphocytic Response (tumor-infiltrating lymphocytes)

40 Shall we map TNM to SNOMED CT? TNM values Label pm1c: Metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehydrogenase (LDH) pn2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension pt2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (ie, not in the main bronchus); or Tumor 5 cm or less in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasi or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung

41 Better use of DICOM in Anatomic Pathology workflow DICOM Modality Work list

42 What is anatomic pathology? It is not radiology Order => report Imaging procedure step is optional Specimen-driven One study = one or more specimen (one or more patients) Slides always available Order => imaging procedure => report Patient driven One study = one patient

43 Modality Work list: Requested procedure, accession number & Study Order & Requested procedure The Order Filler translates the received Orders into Requested Procedure(s) identified by Order Filler Numbers and automatically assigns Study Accession Numbers Accession number <-> Order Filler Number The unique identifier assigned by the Pathology Information System of an Anatomic Pathology laboratory to an imaging Study. As expressed in DICOM Supplement 122: The concept of accession in Anatomic Pathology has been determined to be sufficiently equivalent to an accession in Radiology so that the existing Accession Number at the Study level may be reused for the same purpose and with essentially the existing definition. For Anatomic Pathology, like in Radiology, the Accession Number may correspond to the Order Filler Number, as specified in HL7 v2.x.

44 Modality Work list Procedure step & Series Procedure Step A Procedure Step ( Work Order Step ) is an atomic operation belonging to Requested Procedure, to be performed on one specimen by a single type of device (e.g. immune-histo-chemistry automaton, staining automaton, image acquisition modality). Some Procedure Steps are dedicated to image acquisition Series A subset of an imaging Study acquired from a single specimen by a single acquisition modality. Whenever an image is acquired from a new specimen or involves a new acquisition modality a new Series is created. A new series is also created when an image is acquired for an existing study after the original order has been fulfilled.

45 Modality Work list Requested procedures & procedure steps OR123: Lungectomy Study Case OrderFiller ID Accession Number = One Requested procedure DP07110: Lungectomy DP07110-A: Left upper lobe (gross image) DP07110-A-1: Frozen section, mass DP07110-A-1-1: FS DP07110-A-1-2: H&E DP07110-A-2: Entire mass DP07110-A-2-1: H&E (WSI) Order Series Two Two (imaging) procedure procedure steps steps

46 Modality Work list Requested procedures & procedure steps Order : AP examination of Breast biopsy Requested procedure : Imaging of AP examination of Breast biopsy (at the patient level) = ACCESSION NUMBER = OrderFiller ID (Imaging) procedure step: scanning Slide DP07110-A-5-1 (at the specimen/derived specimen level) Order : Mammography Requested (imaging) procedure : mammography (at the patient level) = ACCESSION NUMBER = OrderFiller ID

47 Modality Work list A mechanism defined to support the imaging workflow, by which the Pathology Information System provides the attributes of the imaging subject to modalities. In anatomic pathology, the imaging subject is a specimen derived from the patient. Query Modality Worklist: Based on a query entered at the Acquisition Modality, a modality worklist is generated listing all the items that satisfy the query. This list of Scheduled Procedure Steps with selected demographic information and information about specimen is returned to the Acquisition Modality. The Modality Worklist provides patient, order (study) and specimen identification and description to be included in the acquired images. The attributes of the Specimen Module have been defined in a Macro construct, and added to the Scheduled Procedure Step Module of Modality Worklist.

48 Modality Work list Requested procedures & procedure steps Order : AP examination of Breast biopsy Requested procedure Procedure step: scanning Slide DP07110-A-5-1 Worklist (attributes of the imaging subject) List of requested procedures (patient/study level) List of procedure steps (specimen/series level) Order : Mammography Requested (imaging) procedure : mammography Worklist (attributes of the imaging subject) List of requested procedures (patient/study level)

49 Modality Work list Specimen description DICOM Supp 122 : Robust new Specimen Module at image level of hierarchy Specimen short/detailed textual description Including specimen ancestry description in case of derived specimen In conformance with DICOM supp122, the short textual description of a specimen retrieved from the Order Filler is a concatenation of the short description of the specimen and all the short descriptions of the specimen ancestry Example : Whole Slide Image of DP07110-A-5-1 DP07110-A: Left upper lobe DP07110-A-5: Left upper lobe/tumor DP07110-A-5-1:H&E DP07110-A-5-1: Left upper lobe/tumor/h&e

50 More information Googlegroup : ihe-anatomic-pathologycommittee@googlegroups.com Road map logy

Ritu Nayar, MD Professor and Vice Chair of Pathology Northwestern University, Feinberg School of Medicine Chicago, IL

Ritu Nayar, MD Professor and Vice Chair of Pathology Northwestern University, Feinberg School of Medicine Chicago, IL Ritu Nayar, MD Professor and Vice Chair of Pathology Northwestern University, Feinberg School of Medicine Chicago, IL email: r-nayar@northwestern.edu Nothing to disclose College of American Pathologists

More information

Introduction to REM-NM Radiation Exposure Monitoring for Nuclear Medicine. Jeff Pohlhammer, Charles Smith

Introduction to REM-NM Radiation Exposure Monitoring for Nuclear Medicine. Jeff Pohlhammer, Charles Smith Introduction to REM-NM Radiation Exposure Monitoring for Nuclear Medicine Jeff Pohlhammer, Charles Smith Agenda A Little History The REM Profile Introduction of REM-NM Profile Features Functional Requirements

More information

Michigan Cancer Surveillance Program

Michigan Cancer Surveillance Program Michigan Cancer Surveillance Program Supplemental Guidance for the Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries, HL7 Clinical Document Architecture (CDA)

More information

Definition of Synoptic Reporting

Definition of Synoptic Reporting Definition of Synoptic Reporting The CAP has developed this list of specific features that define synoptic reporting formatting: 1. All required cancer data from an applicable cancer protocol that are

More information

Barriers to Understanding

Barriers to Understanding Behind the Scenes: The Critical Importance of Cancer Cell Pathology and the Pathologist Sherry T. Emery, M.D., Chief of Pathology Northeast Health System Barriers to Understanding Questions for 2010 What

More information

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade Quality ID #100 (NQF 0392): Colorectal Cancer Resection Pathology Reporting: pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes) with Histologic Grade National Quality Strategy Domain: Effective

More information

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment B REAST STAGING FORM CLINICAL Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery (DCIS) (LCIS) (Paget s) mi c a b c d TUMOR SIZE:

More information

Michigan Cancer Surveillance Program

Michigan Cancer Surveillance Program March, 2016 Version 1.7 Michigan Cancer Surveillance Program Supplemental Guidance for the Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries, HL7 Clinical Document

More information

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment B REAST STAGING FORM Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery (DCIS) (LCIS) (Paget s) mi a b c a b c d TUMOR SIZE: S TAGE

More information

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade Quality ID #100 (NQF 0392): Colorectal Cancer Resection Pathology Reporting: pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes) with Histologic Grade National Quality Strategy Domain: Effective

More information

AJCC-NCRA Education Needs Assessment Results

AJCC-NCRA Education Needs Assessment Results AJCC-NCRA Education Needs Assessment Results Donna M. Gress, RHIT, CTR Survey Tool 1 Survey Development, Delivery, Analysis THANKS to NCRA for the following work Developed survey with input from partners

More information

BreastScreen Victoria Annual Statistical Report

BreastScreen Victoria Annual Statistical Report BreastScreen Victoria Annual Statistical Report 005 Produced by: BreastScreen Victoria Coordination Unit Level, Pelham Street, Carlton South Victoria 05 PH 0 9660 6888 FX 0 966 88 EM info@breastscreen.org.au

More information

Rebooting Cancer Data Through Structured Data Capture GEMMA LEE NAACCR CONFERENCE JUNE, 2017

Rebooting Cancer Data Through Structured Data Capture GEMMA LEE NAACCR CONFERENCE JUNE, 2017 Rebooting Cancer Data Through Structured Data Capture GEMMA LEE NAACCR CONFERENCE JUNE, 2017 Acknowledgement Richard Moldwin, MD, PhD, CAP Sandy Jones, CDC Wendy Blumenthal, CDC David Kwan, Cancer Care

More information

STAGE CATEGORY DEFINITIONS

STAGE CATEGORY DEFINITIONS CLINICAL Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery TX Tis Tis (DCIS) Tis (LCIS) Tis (Paget s) T1 T1mi T1a T1b T1c a b c

More information

Collaborative Stage. Site-Specific Instructions - LUNG

Collaborative Stage. Site-Specific Instructions - LUNG Slide 1 Collaborative Stage Site-Specific Instructions - LUNG In this presentation, we are going to review the AJCC Cancer Staging criteria for the lung primary site. Slide 2 Reading Assignments As each

More information

ACRIN 6666 Therapeutic Surgery Form

ACRIN 6666 Therapeutic Surgery Form S1 ACRIN 6666 Therapeutic Surgery Form 6666 Instructions: Complete a separate S1 form for each separate area of each breast excised with the intent to treat a cancer (e.g. each lumpectomy or mastectomy).

More information

IHE APSR the German view

IHE APSR the German view IHE APSR the German view Gunter Haroske 1 & Thomas Schrader 2,3 Institute für Pathologie KH Dresden-Friedrichstadt 1 HU Berlin Charite 2 FH Brandenburg 3 Background for HL7 Communication requires that

More information

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ). SOLID TUMORS WORKSHOP Cases for review Prostate Cancer Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ). January 2009 PSA 4.4, 20% free; August 2009 PSA 5.2; Sept 2009

More information

IHE Quality, Research and Public Health Technical Framework Supplement. Early Hearing Care Plan (EHCP) Trial Implementation

IHE Quality, Research and Public Health Technical Framework Supplement. Early Hearing Care Plan (EHCP) Trial Implementation Integrating the Healthcare Enterprise 5 IHE Quality, Research and Public Health Technical Framework Supplement 10 Early Hearing Care Plan (EHCP) Trial Implementation 15 20 Date: September 2, 2011 Author:

More information

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade Quality ID #99 (NQF 0391): Breast Cancer Resection Pathology Reporting: pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes) with Histologic Grade National Quality Strategy Domain: Effective

More information

NPCR-AERRO S PARTNERSHIP WITH IHE: ENSURING CANCER S CONNECTIVITY WITH THE EMR/EHR

NPCR-AERRO S PARTNERSHIP WITH IHE: ENSURING CANCER S CONNECTIVITY WITH THE EMR/EHR NPCR-AERRO S PARTNERSHIP WITH IHE: ENSURING CANCER S CONNECTIVITY WITH THE EMR/EHR Wendy Blumenthal, MPH Epidemiologist NAACCR Annual Conference June 24, 2010 National Center for Chronic Disease Prevention

More information

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix. Uterine Cervix Protocol applies to all invasive carcinomas of the cervix. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition and FIGO 2001 Annual Report Procedures Cytology (No Accompanying

More information

Invasive Papillary Breast Carcinoma

Invasive Papillary Breast Carcinoma 410 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the

More information

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade Measure #99 (NQF 0391): Breast Cancer Resection Pathology Reporting: pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes) with Histologic Grade National Quality Strategy Domain: Effective

More information

GOALS AND OBJECTIVES BREAST PATHOLOGY

GOALS AND OBJECTIVES BREAST PATHOLOGY GOALS AND OBJECTIVES BREAST PATHOLOGY LEVEL: PGY2, PGY3, PGY5 A number of these rotations are introductory in nature, as they are major subspecialties, and are followed by two more blocks in PGY-3, during

More information

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity. Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity. Background: 46 year old married premenopausal female with dense breasts has noticed

More information

TRIAL SYNOPSIS LORIS. The Low Risk DCIS Trial. Chief Investigator. Miss Adele Francis

TRIAL SYNOPSIS LORIS. The Low Risk DCIS Trial. Chief Investigator. Miss Adele Francis TRIAL SYNOPSIS LORIS Chief Investigator The Low Risk DCIS Trial Miss Adele Francis ISRCTN No. 27544579 Sponsor University of Birmingham, United Kingdom Trial Design Objectives of Feasibility Study A multi-centre,

More information

Pathology Report Patient Companion Guide

Pathology Report Patient Companion Guide Pathology Report Patient Companion Guide Breast Cancer - Understanding Your Pathology Report Pathology Reports can be overwhelming. They contain scientific terms that are unfamiliar and might be a bit

More information

Protocol applies to melanoma of cutaneous surfaces only.

Protocol applies to melanoma of cutaneous surfaces only. Melanoma of the Skin Protocol applies to melanoma of cutaneous surfaces only. Procedures Biopsy (No Accompanying Checklist) Excision Re-excision Protocol revision date: January 2005 Based on AJCC/UICC

More information

MBP AP 3 Core Curriculum

MBP AP 3 Core Curriculum MBP AP 3 Core Curriculum The MBP AP3 core curriculum focuses on providing pathologists with the knowledge and skills needed to be a vital member of the patient care team. Further, the curriculum fulfills

More information

Standard 4.6: The Importance of CAP Protocols and Understanding Synoptic Reporting

Standard 4.6: The Importance of CAP Protocols and Understanding Synoptic Reporting Standard 4.6: The Importance of CAP Protocols and Understanding Synoptic Reporting Jerry Hussong, MD, FCAP Cedars Sinai Medical Center, Los Angeles CA M. Asa Carter, CTR Manager, Accreditation and Standards

More information

Educational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery

Educational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery Educational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery Goal The goal of the Breast Surgery rotation is to develop the knowledge, skills and attitudes necessary to evaluate,

More information

Protocol for the Examination of Specimens from Patients with Invasive Carcinoma of the Breast

Protocol for the Examination of Specimens from Patients with Invasive Carcinoma of the Breast Protocol for the Examination of Specimens from Patients with Invasive Carcinoma of the Breast Protocol applies to all invasive carcinomas of the breast, including ductal carcinoma in situ (DCIS) with microinvasion.

More information

An Update: Lung Cancer

An Update: Lung Cancer An Update: Lung Cancer Andy Barlow Consultant in Respiratory Medicine Lead Clinician for Lung Cancer (West Herts Hospitals NHS Trust) Lead for EBUS-Harefield Hospital (RB&HFT) Summary Lung cancer epidemiology

More information

Quality ID #263: Preoperative Diagnosis of Breast Cancer National Quality Strategy Domain: Effective Clinical Care

Quality ID #263: Preoperative Diagnosis of Breast Cancer National Quality Strategy Domain: Effective Clinical Care Quality ID #263: Preoperative Diagnosis of Breast Cancer National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:

More information

NPQR Quality Payment Program (QPP) Measures 21_18247_LS.

NPQR Quality Payment Program (QPP) Measures 21_18247_LS. NPQR Quality Payment Program (QPP) Measures 21_18247_LS MEASURE ID: QPP 99 MEASURE TITLE: Breast Cancer Resection Pathology Reporting pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes)

More information

Procedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy

Procedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy Prostate Gland Protocol applies to invasive carcinomas of the prostate gland. Protocol web posting date: July 2006 Protocol effective date: April 2007 Based on AJCC/UICC TNM, 6 th edition Procedures Needle

More information

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology Slide 1 Investigation and management of lung cancer Robert Rintoul Department of Thoracic Oncology Papworth Hospital Slide 2 Epidemiology Second most common cancer in the UK (after breast). 38 000 new

More information

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS Exercise 15: CSv2 Data Item Coding Instructions ANSWERS CS Tumor Size Tumor size is the diameter of the tumor, not the depth or thickness of the tumor. Chest x-ray shows 3.5 cm mass; the pathology report

More information

An Introduction to CPT Coding

An Introduction to CPT Coding An Introduction to CPT Coding Michael L. Talbert, M.D., FCAP Copyright 2005 College of American Pathologists (CAP). All rights reserved. Participants are permitted to duplicate the materials for educational

More information

IHE Cardiology Technical Framework Supplement. Cardiac Imaging Report Content (CIRC) Trial Implementation

IHE Cardiology Technical Framework Supplement. Cardiac Imaging Report Content (CIRC) Trial Implementation Integrating the Healthcare Enterprise 5 IHE Cardiology Technical Framework Supplement 10 Cardiac Imaging Report Content (CIRC) 15 Trial Implementation Date: July 1, 2011 20 Editor: IHE Cardiology Technical

More information

Coding Pitfalls 9/11/14

Coding Pitfalls 9/11/14 Coding Pitfalls 2013 2014 NAACCR Webinar Series September 11, 2014 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar

More information

Staging for Residents, Nurses, and Multidisciplinary Health Care Team

Staging for Residents, Nurses, and Multidisciplinary Health Care Team Staging for Residents, Nurses, and Multidisciplinary Health Care Team Donna M. Gress, RHIT, CTR Validating science. Improving patient care. Learning Objectives Introduce the concept and history of stage

More information

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition Small Intestine Protocol applies to all invasive carcinomas of the small intestine, including those with focal endocrine differentiation. Excludes carcinoid tumors, lymphomas, and stromal tumors (sarcomas).

More information

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 LSU HEALTH SCIENCES CENTER NSCLC Guidelines Feist-Weiller Cancer Center Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 Initial Evaluation/Intervention: 1. Pathology Review 2. History and Physical

More information

Pediatric Echo Structured Reporting An Experience Sharing

Pediatric Echo Structured Reporting An Experience Sharing THE DICOM 2013 INTERNATIONAL CONFERENCE & SEMINAR March 14-16 Bangalore, India Bindhu M Pediatric Echo Structured Reporting An Experience Sharing Philips Healthcare Technical Specialist Bangalore, India

More information

Concordance with Breast Cancer Pathology Reporting Practice Guidelines

Concordance with Breast Cancer Pathology Reporting Practice Guidelines Concordance with Breast Cancer Pathology Reporting Practice Guidelines Neal W Wilkinson, MD, FACS, Azin Shahryarinejad, MD, Janet S Winston, MD, Nancy Watroba, MPA, Stephen B Edge, MD, FACS BACKGROUND:

More information

Quality ID #250 (NQF 1853): Radical Prostatectomy Pathology Reporting National Quality Strategy Domain: Effective Clinical Care

Quality ID #250 (NQF 1853): Radical Prostatectomy Pathology Reporting National Quality Strategy Domain: Effective Clinical Care Quality ID #250 (NQF 1853): Radical Prostatectomy Pathology Reporting National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process

More information

FNA Thyroid Cytology Structured Reporting Proforma

FNA Thyroid Cytology Structured Reporting Proforma FNA Thyroid Cytology Structured Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.03). Family name Given name(s) Date of birth S1.02 Clinical details Male Female Intersex/indeterminate

More information

Breast Pathology. Breast Development

Breast Pathology. Breast Development Breast Pathology Lecturer: Hanina Hibshoosh, M.D. Reading: Kumar, Cotran, Robbins, Basic Pathology, 6th Edition, pages 623-635 Breast Development 5th week - thickening of the epidermis - milk line 5th

More information

Problems in staging breast carcinoma

Problems in staging breast carcinoma Problems in staging breast carcinoma Primary systemic therapy (PST) of breast carcinoma pathologists tasks Dr. Janina Kulka, 2nd Department of Pathology, Semmelweis University Budapest Austro-Hungarian

More information

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules Case 1 72 year old white female presents with a nodular thyroid. This was biopsied in

More information

College of American Pathologists. Pathology Performance Measures included in CMS 2012 PQRS

College of American Pathologists. Pathology Performance Measures included in CMS 2012 PQRS College of American Pathologists Pathology Performance Measures included in CMS 2012 PQRS Breast Cancer Resection Pathology Reporting Measure #99 pt category (primary tumor) and pn category (regional lymph

More information

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity. Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity. Background: 46 year old married premenopausal female with dense breasts has noticed

More information

Requirements for Abstracted Text

Requirements for Abstracted Text Slide 1 Requirements for Abstracted Text Principles of Abstracting Lesson 3: Purpose of Text Slide 2 Available Text Fields Place of Diagnosis Immunotherapy Chemotherapy Hormone Therapy Other Therapy Radiation

More information

GUIDELINES FOR CANCER IMAGING Lung Cancer

GUIDELINES FOR CANCER IMAGING Lung Cancer GUIDELINES FOR CANCER IMAGING Lung Cancer Greater Manchester and Cheshire Cancer Network Cancer Imaging Cross-Cutting Group April 2010 1 INTRODUCTION This document is intended as a ready reference for

More information

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition Colon and Rectum Protocol applies to all invasive carcinomas of the colon and rectum. Carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix are excluded. Protocol revision date: January

More information

Seventh Edition Staging 2017 Breast

Seventh Edition Staging 2017 Breast Seventh Edition Staging 2017 Breast Donna M. Gress, RHIT, CTR Validating science. Improving patient care. No materials in this presentation may be repurposed in print or online without the express written

More information

Digital Imaging and Communications in Medicine (DICOM) Supplement 50: Mammography Computer-Aided Detection SR SOP Class

Digital Imaging and Communications in Medicine (DICOM) Supplement 50: Mammography Computer-Aided Detection SR SOP Class Digital Imaging and Communications in Medicine (DICOM) Supplement 50: Mammography Computer-Aided Detection SR SOP Class Status: Letter Ballot Text February 2, 2001 DICOM Standards Committee 1300 N. 17

More information

LUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL

LUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL LUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL ( ) Tx Primary tumor cannot be assessed, or tumor proven by the presence of malignant cells in sputum or bronchial washings but not visualized by imaging

More information

Breast Cancer Diagnosis, Treatment and Follow-up

Breast Cancer Diagnosis, Treatment and Follow-up Breast Cancer Diagnosis, Treatment and Follow-up What is breast cancer? Each of the body s organs, including the breast, is made up of many types of cells. Normally, healthy cells grow and divide to produce

More information

Case Scenario 1: Breast

Case Scenario 1: Breast Case Scenario 1: Breast A 63 year old white female presents with a large mass in her left breast. 4/15/13 Mammogram/US: 1. Left breast mammographic and sonographic at 3:00 measuring 7.1 cm highly suggestive

More information

Integrating the Healthcare Enterprise (IHE) Structured Data Capture (SDC) Use Case: Cancer Registry Reporting

Integrating the Healthcare Enterprise (IHE) Structured Data Capture (SDC) Use Case: Cancer Registry Reporting Integrating the Healthcare Enterprise (IHE) Structured Data Capture (SDC) Use Case: Cancer Registry Reporting Sandy Jones Public Health Advisor Cancer Surveillance Branch, CDC Vijay Shah Director, Health

More information

46. Merkel Cell Carcinoma

46. Merkel Cell Carcinoma 1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting

More information

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research NCCN/JCCNB Seminar in Japan April 15, 2012 Case study 1 Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research Present illness: A 50y.o.premenopausal

More information

The North American Association of Central Cancer Registries, Inc. (NAACCR) Interoperability Activities

The North American Association of Central Cancer Registries, Inc. (NAACCR) Interoperability Activities The North American Association of Central Cancer Registries, Inc. (NAACCR) Interoperability Activities Lori A. Havener, CTR Program Manager of Standards Public Health Data Standards Consortium 2008 Annual

More information

IHE Cardiology Technical Framework Supplement. Cath Report Content (CRC) Trial Implementation

IHE Cardiology Technical Framework Supplement. Cath Report Content (CRC) Trial Implementation Integrating the Healthcare Enterprise 5 IHE Cardiology Technical Framework Supplement 10 Report Content (CRC) 15 Trial Implementation 20 Date: October 11, 2013 Author: IHE Cardiology Technical Committee

More information

North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer

North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer THIS DOCUMENT IS North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer [Based on WOSCAN NSCLC CMG with further extensive consultation within NOSCAN] UNCONTROLLED

More information

Quality assurance and quality control in pathology in breast disease centers

Quality assurance and quality control in pathology in breast disease centers Quality assurance and quality control in pathology in breast disease centers Judith Sandbank M.D. Pathology Assaf-Harofeh Medical Center ISRAEL jsandbank@asaf.health.gov.il 1 st IBDC, 28 th January, 2011

More information

CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release

CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release 2 REVISION HISTORY Date Author / Editor Comments 5/19/2014 Jaleh Mirza Created the document 8/12/2014 Samantha Spencer/Jaleh

More information

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles Prostate Cancer Histopathology Reporting Proforma (Radical Prostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family name Given name(s) Date of birth Sex Male

More information

Q: How do you clinically code the N if the nodes are stated to be positive on mammogram/us or other imaging? No biopsy of nodes was done.

Q: How do you clinically code the N if the nodes are stated to be positive on mammogram/us or other imaging? No biopsy of nodes was done. Q&A Breast Webinar Q: One of my investigators is interested in knowing when Oncotype DX data collection was implemented. That data is collected in SSFs 22 and 23. I remember that the SSFs for breast were

More information

Echocardiography A powerful module of MediConnect

Echocardiography A powerful module of MediConnect Echocardiography A powerful module of MediConnect WHERE IT ALL COMES TOGETHER MEDICONNECT AN OVERVIEW Integrating the latest IT technologies with medical expertise within an existing clinical infrastructure

More information

BREAST PATHOLOGY. Fibrocystic Changes

BREAST PATHOLOGY. Fibrocystic Changes BREAST PATHOLOGY Lesions of the breast are very common, and they present as palpable, sometimes painful, nodules or masses. Most of these lesions are benign. Breast cancer is the 2 nd most common cause

More information

Q&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast

Q&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast Collecting Cancer Data Breast NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar

More information

L ARYNX S TAGING F ORM

L ARYNX S TAGING F ORM CLI N I CA L Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery TX T0 Tis a b L ARYNX S TAGING F ORM LATERALITY: TUMOR SIZE: left

More information

Carcinoma of the Renal Pelvis and Ureter Histopathology

Carcinoma of the Renal Pelvis and Ureter Histopathology Carcinoma of the Renal Pelvis and Ureter Histopathology Reporting Proforma (NEPHROURETERECTOMY AND URETERECTOMY) Includes the International Collaboration on Cancer reporting dataset denoted by * Family

More information

The International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements

The International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements Page 1 Contents 1.1. Registration... 2 1.2. Patient Characteristics... 3 1.3. Laboratory Values at Diagnosis... 5 1.4. Lung Cancers with Multiple Lesions... 6 1.5. Primary Tumour Description... 10 1.6.

More information

6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck

6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck 1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting

More information

ANATOMICAL PATHOLOGY TARIFF

ANATOMICAL PATHOLOGY TARIFF ANATOMICAL PATHOLOGY TARIFF A GUIDE TO UTILISATION. The following guidelines have been agreed by consensus of Anatomical Pathologists who are members of the Anatomical Pathologist s Group, or the National

More information

Pancreas (Exocrine) Protocol applies to all carcinomas of the exocrine pancreas.

Pancreas (Exocrine) Protocol applies to all carcinomas of the exocrine pancreas. Pancreas (Exocrine) Protocol applies to all carcinomas of the exocrine pancreas. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition Procedures Cytology (No Accompanying Checklist)

More information

Descriptor Definition Author s notes TNM descriptors Required only if applicable; select all that apply multiple foci of invasive carcinoma

Descriptor Definition Author s notes TNM descriptors Required only if applicable; select all that apply multiple foci of invasive carcinoma S5.01 The tumour stage and stage grouping must be recorded to the extent possible, based on the AJCC Cancer Staging Manual (7 th Edition). 11 (See Tables S5.01a and S5.01b below.) Table S5.01a AJCC breast

More information

Automatic Extraction of Synoptic Data. George Cernile Artificial Intelligence in Medicine AIM

Automatic Extraction of Synoptic Data. George Cernile Artificial Intelligence in Medicine AIM Automatic Extraction of Synoptic Data George Cernile Artificial Intelligence in Medicine AIM Agenda Background Technology used Demonstration Questions How often are checklist elements included in a report,

More information

Purpose. Encourage standard exchange of data between two key public health partners

Purpose. Encourage standard exchange of data between two key public health partners Reporting Pathology Protocols for Colorectal Cancer 2005 NAACCR Conference: June 9, 2005 Ken Gerlach: CDC-NPCR Bette Smith: Ohio Cancer Registry Kathleen Davidson-Allen: PHI/California Cancer Registry

More information

Chapter 2 Staging of Breast Cancer

Chapter 2 Staging of Breast Cancer Chapter 2 Staging of Breast Cancer Zeynep Ozsaran and Senem Demirci Alanyalı 2.1 Introduction Five decades ago, Denoix et al. proposed classification system (tumor node metastasis [TNM]) based on the dissemination

More information

Measure #250 (NQF 1853): Radical Prostatectomy Pathology Reporting National Quality Strategy Domain: Effective Clincial Care

Measure #250 (NQF 1853): Radical Prostatectomy Pathology Reporting National Quality Strategy Domain: Effective Clincial Care Measure #250 (NQF 1853): Radical Prostatectomy Pathology Reporting National Quality Strategy Domain: Effective Clincial Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage

More information

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I Changes and Clarifications 16 th Edition April 15, 2016 Quick Look- Updates to Volume

More information

Melanoma Case Scenario 1

Melanoma Case Scenario 1 Melanoma Case Scenario 1 History and physical 11/5/16 Patient is a single, 48-year-old male in good health who presented to his primary physician for a yearly physical exam during which a 3.4 x 2.8 x 1.5

More information

Virtual Microscopy: Express Surgical Pathology Consultation. Mercè Jordà, University of Miami, Florida

Virtual Microscopy: Express Surgical Pathology Consultation. Mercè Jordà, University of Miami, Florida Virtual Microscopy: Express Surgical Pathology Consultation Mercè Jordà, University of Miami, Florida Telepathology versus Virtual microscopy (Digital Pathology) Telepathology Use of telecommunications

More information

Prostate Case Scenario 1

Prostate Case Scenario 1 Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has

More information

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to: 1 ANNEX 1 OBJECTIVES At the completion of the training period, the fellow should be able to: 1. Breast Surgery Evaluate and manage common benign and malignant breast conditions. Assess the indications

More information

A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues

A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only Specifications: No. of cases: 12 Tissue type: Breast cancer tissues with corresponding

More information

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy Authors: Dr Gordon Armstrong, Dr Sue Pritchard 1. General Comments 1.1 Cancer reporting: Biopsies

More information

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB. 1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting

More information

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY Colorectal Cancer Structured Pathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.03). Family name Given name(s) Date of birth DD MM YYYY S1.02 Clinical details

More information

Sentinel nodes. Location: Location: S1.04 Principal clinician. G1.01 Record other relevant information. S2.01 Number of specimens submitted

Sentinel nodes. Location: Location: S1.04 Principal clinician. G1.01 Record other relevant information. S2.01 Number of specimens submitted Invasive Breast Cancer Histopathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.01). S1.01 Identification Family name Given name(s) Date of birth DD MM YYYY

More information

Basement membrane in lobule.

Basement membrane in lobule. Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.

More information

EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013

EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013 EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013 Head and Neck Coding and Staging Head and Neck Coding and Staging Anatomy & Primary Site Sequencing and MPH

More information

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery. Case Scenario 1 July 10, 2010 A 67-year-old male with squamous cell carcinoma of the mid thoracic esophagus presents for surgical resection. The patient has completed preoperative chemoradiation. This

More information

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines SEER EOD and Summary Stage KCR 2018 SPRING TRAINING Overview What is SEER EOD Ambiguous Terminology General Guidelines EOD Primary Tumor EOD Regional Nodes EOD Mets SEER Summary Stage 2018 Site Specific

More information